$1.72 Earnings Per Share Expected for CME Group Inc (NASDAQ:CME) This Quarter

Wall Street brokerages predict that CME Group Inc (NASDAQ:CME) will announce earnings per share (EPS) of $1.72 for the current fiscal quarter, Zacks reports. Five analysts have issued estimates for CME Group’s earnings, with estimates ranging from $1.57 to $1.81. CME Group reported earnings per share of $1.45 during the same quarter last year, which would suggest a positive year over year growth rate of 18.6%. The firm is scheduled to report its next quarterly earnings results before the market opens on Wednesday, October 30th.

According to Zacks, analysts expect that CME Group will report full year earnings of $6.79 per share for the current financial year, with EPS estimates ranging from $6.60 to $7.04. For the next financial year, analysts forecast that the business will report earnings of $7.43 per share, with EPS estimates ranging from $7.07 to $8.09. Zacks’ EPS calculations are an average based on a survey of sell-side research analysts that follow CME Group.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.76 EPS for the quarter, beating the consensus estimate of $1.75 by $0.01. The company had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. CME Group’s revenue for the quarter was up 20.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.74 earnings per share.

CME has been the subject of several recent analyst reports. UBS Group boosted their price objective on shares of CME Group from $214.00 to $220.00 and gave the company a “neutral” rating in a research note on Thursday. ValuEngine cut shares of CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday. Berenberg Bank cut shares of CME Group from a “buy” rating to a “hold” rating and reduced their price objective for the company from $236.00 to $227.00 in a research note on Thursday, September 19th. Deutsche Bank boosted their price objective on shares of CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research note on Friday, August 9th. Finally, Wells Fargo & Co boosted their price objective on shares of CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a research note on Wednesday, July 3rd. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and seven have assigned a buy rating to the company’s stock. CME Group has an average rating of “Hold” and a consensus target price of $200.43.

NASDAQ:CME traded up $6.59 during mid-day trading on Monday, hitting $216.02. 1,013,434 shares of the stock traded hands, compared to its average volume of 1,549,347. The business’s 50-day moving average price is $213.57 and its 200 day moving average price is $194.96. The company has a market cap of $77.36 billion, a PE ratio of 31.67, a price-to-earnings-growth ratio of 4.47 and a beta of 0.20. CME Group has a 12-month low of $161.05 and a 12-month high of $224.91. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15.

The business also recently declared a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Tuesday, September 10th were paid a $0.75 dividend. The ex-dividend date was Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a yield of 1.39%. CME Group’s dividend payout ratio is presently 43.99%.

In other CME Group news, insider Sean Tully sold 7,200 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $223.13, for a total value of $1,606,536.00. Following the completion of the transaction, the insider now owns 19,923 shares of the company’s stock, valued at approximately $4,445,418.99. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $217.62, for a total transaction of $544,050.00. Following the completion of the transaction, the chief financial officer now directly owns 30,354 shares of the company’s stock, valued at approximately $6,605,637.48. The disclosure for this sale can be found here. In the last three months, insiders sold 59,626 shares of company stock valued at $12,255,934. Corporate insiders own 1.20% of the company’s stock.

Hedge funds have recently added to or reduced their stakes in the business. Advantage Investment Management LLC lifted its holdings in shares of CME Group by 119.0% in the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock worth $36,000 after acquiring an additional 100 shares during the last quarter. Westside Investment Management Inc. bought a new stake in shares of CME Group in the 2nd quarter worth approximately $38,000. Private Capital Group LLC lifted its holdings in shares of CME Group by 44.9% in the 2nd quarter. Private Capital Group LLC now owns 242 shares of the financial services provider’s stock worth $40,000 after acquiring an additional 75 shares during the last quarter. Permanens Capital L.P. bought a new stake in shares of CME Group in the 1st quarter worth approximately $41,000. Finally, Patriot Financial Group Insurance Agency LLC lifted its holdings in shares of CME Group by 209.4% in the 2nd quarter. Patriot Financial Group Insurance Agency LLC now owns 263 shares of the financial services provider’s stock worth $53,000 after acquiring an additional 178 shares during the last quarter. 84.85% of the stock is owned by institutional investors and hedge funds.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Story: What does cost of debt say about a company’s financial health?

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.